Foresite Capital Management IV, LLC

2.1

2.1

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Eikon Therapeutics Inc (EIKN)

Transaction date 4 Feb 2026

Purchase

Price

159.84

Quantity 33,439 -38.2%

Value US$2,732,936

Comments Filing

Kinnate Biopharma Inc (KNTE)

Transaction date 8 May 2023

Purchase

Price

299.87

Quantity 98,802 +47.6%

Value US$2,730,835

Comments Filing

Kinnate Biopharma Inc (KNTE)

Transaction date 8 May 2023

Purchase

Price

436.51

Quantity 80,978 +40.7%

Value US$1,185,047

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-02-06	2026-02-04	Eikon Therapeutics Inc (EIKN)	B Purchase	33,439 -38.2% 159.84 US$2,732,936	33,439 -38.2%	159.84	US$2,732,936
2023-05-10	2023-05-08	Kinnate Biopharma Inc (KNTE)	B Purchase	98,802 +47.6% 299.87 US$2,730,835	98,802 +47.6%	299.87	US$2,730,835
2023-05-10	2023-05-08	Kinnate Biopharma Inc (KNTE)	B Purchase	80,978 +40.7% 436.51 US$1,185,047	80,978 +40.7%	436.51	US$1,185,047